Fair enough, although in my defence I described Boiron as 'tiny' as compared to GSK, and at almost 65 times the size I think you could easily argue that point.
That said, I know from working in the US, and from my many pharma contacts over there that the main driving force of the industry, as...
Not so sure about your Boiron figures. According to the interwebz, annual turnover (2010):
Boiron - 520 million Euros, 4,081 employees
GSK - 32,276 million Euros, 100,000 employees
Yes, Boiron spent 20 times more on marketing than R&D in 2009 but they are a tiny organisation compared to the...